Recent studies suggest that IDH1 R132 mutations are present in the majority of common adult gliomas but only occur in small fraction of pGBMs, and patients with IDH1 mutation have a better outcome than those with wild-type IDH1 in gliomas [5]. Here, IDH1 is linked to central nervous system cancer.